FDA OKs New Option for Uncomplicated UTIs in Women, Girls

(MedPage Today) -- The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 years and up, GSK announced on Tuesday.
Results of two phase III trials -- EAGLE-2 and EAGLE-3 -- supported...